Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression.
Park SM, Kim KH, Yoon JH, D'Angelo F, Choi SA, Kim CI, Koo H, Park S, Kim H, Sundara Raj S, Kim SS, Park AK, Koh EJ, Kim SI, Shim YM, Kwang-Hoon L, Kim EE, Phi JH, Jo YS, Nam DH, Hwang D, Hyeon DY, Huh S, Kwon HJ, Ha S, Park S, Shin H, Kwon JT, Yoo H, Gwak HS, D Taylor M, Park BJ, Sa JK, Kim Y, Iavarone A, Park SH, Kim SK, Park JB.
Park SM, et al. Among authors: park bj.
Exp Mol Med. 2026 Jun 5. doi: 10.1038/s12276-026-01732-0. Online ahead of print.
Exp Mol Med. 2026.
PMID: 42249086